PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Study reports 2-year outcomes of diabetic macular edema treatment

2012-04-10
(Press-News.org) CHICAGO – A randomized controlled trial involving patients with persistent clinically significant diabetic macular edema (swelling of the retina) suggests the greater efficacy of bevacizumab compared with macular laser therapy that was previously demonstrated at 12 months was maintained through 24 months, according to a report published Online First by Archives of Ophthalmology, a JAMA Network publication.

Modified Early Treatment Diabetic Retinopathy Study (ETDRS) macular laser therapy (MLT) has been the mainstay of treatment for clinically significant diabetic macular edema (CSME) for the last three decades. The procedure reduces the risk of moderate visual loss but visual acuity improves (a 15-letter gain at three years) in less than 3 percent of patients so better treatments have been sought, the authors write in their study background.

Ranjan Rajendram, M.D., F.R.C.Ophth., of Moorfields Eye Hospital, London, and colleagues report on the two-year outcomes of the BOLT study, a prospective randomized controlled trial of 80 patients that evaluated intravitreous bevacizumab (injections into the eye) and modified ETDRS MLT in patients with CSME.

At two years, the mean (average) ETDRS best-corrected visual acuity was 64.4 (Snellen visual acuity equivalent: 20/50) in the bevacizumab group and 54.8 (Snellen equivalent 20/80) in the MLT group, a mean gain of 8.6 letters for bevacizumab and a mean loss of 0.5 letters for MLT. The bevacizumab group gained a median of nine ETDRS letters versus 2.5 ETDRS letters for MLT at 24 months compared with baseline. At 24 months, 49 percent of patients gained 10 or more ETDRS letters and 32 percent gained 15 or more letters in the bevacizumab group compared with 7 percent and 4 percent in the MLT group.

"In conclusion, this investigator-initiated single-center study provides evidence for the longer-term use of bevacizumab in the treatment of persistent DME [diabetic macular edema]," the authors note "Visual acuity benefit was maintained through two years with a reduced injection frequency in the second year despite the long duration of DME and multiple MLTs before entering the study. This finding will be reassuring to physicians charged with delivery of this relatively new treatment."

###(Arch Ophthalmol. Published online April 9, 2012. doi:10.1001/archophthalmol.2012.393. Available pre-embargo to the media at www.jamamedia.org.)

Editor's Note: This work was supported by grants from Moorfields Special Trustees and the National Institute for Health Research UK to the Biomedical Research Centre for Ophthalmology based at Moorfields Eye Hospital, National Health Service Foundation Trust and the UCL Institute of Ophthalmology. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

To contact corresponding author Philip G. Hykin, M.D., F.R.C.Ophth, email phil.hykin@moorfields.nhs.uk.


ELSE PRESS RELEASES FROM THIS DATE:

MU researchers find identical DNA codes in different plant species

2012-04-10
COLUMBIA, Mo. -- Analyzing massive amounts of data officially became a national priority recently when the White House Office of Science and Technology Policy announced the Big Data Research and Development Initiative. A multi-disciplinary team of University of Missouri researchers rose to the big data challenge when they solved a major biological question by using a groundbreaking computer algorithm to find identical DNA sequences in different plant and animal species. "Our algorithm found identical sequences of DNA located at completely different places on multiple ...

Changes in monkeys' social status affect their genes

2012-04-10
DURHAM, N.C. -- A female's social status affects how her genes turn on and off, and those who rank higher tend to be healthier -- so long as their social status doesn't decline, according to a study of rhesus macaques published in the April 9 Proceedings of the National Academy of Sciences. The study is the first to use an experimental approach to observe how gene expression patterns across a range of genes correlate with an animal's social dominance. It estimates that gene expression can predict the social status of an individual with 80 percent accuracy. "Our study ...

Social stress that molds monkey immune system helps researchers understand how stress affects humans

2012-04-10
If a monkey's social status changes, her immune system changes along with it say researchers who conducted the study with rhesus macaques at the Yerkes National Primate Research Center. This finding may have implications for how the stress of low socioeconomic status affects human health and how individuals' bodies adapt after a shift in their social environment. The results are published this week in the Proceedings of the National Academy of Sciences Early Edition. Researchers led by Jenny Tung, PhD, say they can predict a rhesus macaque's rank within a small group ...

2 genetic deletions in human genome linked to the development of aggressive prostate cancer

2012-04-10
NEW YORK (April 9, 2012 ) -- An international research team led by Weill Cornell Medical College investigators have discovered two inherited-genetic deletions in the human genome linked to development of aggressive prostate cancer. The findings, published online today in the Proceedings of the National Academy of Sciences (PNAS), indicate a man's risk of developing prostate cancer either triples or quadruples, depending on the genetic variant they inherit. In the study, one genetic deletion is shown to affect the functioning of a known gene, while the other, found ...

Diet may treat some gene mutations

2012-04-10
BETHESDA, MD -- April 9, 2012 -- Scientists have moved a step closer to correcting some unhealthy gene mutations with diet, according to a new research report appearing in the April 2012 issue of the journal GENETICS (http://www.genetics.org/). Researchers from the University of California, Berkeley, determined variations and responses to vitamin treatment in the human cystathionine beta synthase gene, which when defective, causes the disease homocystinuria, an inherited metabolic disorder sometimes treatable with vitamin B6. After the analysis, scientists correlated specific ...

Summer temperature variability may increase mortality risk for elderly with chronic disease

2012-04-10
Boston, MA – New research from Harvard School of Public Health (HSPH) suggests that seemingly small changes in summer temperature swings—as little as 1°C more than usual—may shorten life expectancy for elderly people with chronic medical conditions, and could result in thousands of additional deaths each year. While previous studies have focused on the short-term effects of heat waves, this is the first study to examine the longer-term effects of climate change on life expectancy. The study will be published online April 9, 2012 in the Proceedings of the National Academy ...

Discover the Best Real Money iPad Casinos at iPadCasinoGames.com

Discover the Best Real Money iPad Casinos at iPadCasinoGames.com
2012-04-10
The release of the new iPad must surely have convinced even the hardest of cynics that the Apple tablet computer is here to stay. This is particularly great news for mobile casino enthusiasts who like to play a quick game of blackjack, roulette, craps or slots while on the move. The success of the latest Apple tablet looks set to revolutionise the world of iPad Casinos in the near future. Most of us at this stage have played real money casino apps on our iPhone or Android smartphones and have enjoyed their many benefits. Blackjack, keno and video poker apps look and ...

UCF scientists use nanotechnology to hunt for hidden pathogens

UCF scientists use nanotechnology to hunt for hidden pathogens
2012-04-10
Researchers at the University of Central Florida have developed a novel technique that may give doctors a faster and more sensitive tool to detect pathogens associated with inflammatory bowel disease, including Crohn's disease. The new nanoparticle-based technique also may be used for detection of other microbes that have challenged scientists for centuries because they hide deep in human tissue and are able to reprogram cells to successfully evade the immune system. The microbes reappear years later and can cause serious health problems such as seen in tuberculosis ...

Novel compound demonstrates anti-leukemic effect in zebrafish, shows promise for human treatment

2012-04-10
(WASHINGTON, April 9, 2012) –A novel anti-leukemia compound with little toxicity successfully treated zebrafish with T-cell acute lymphoblastic leukemia (T-ALL), suggesting its potential to become a new highly targeted therapy for humans – even those resistant to conventional therapies – according to results from a study published online today in Blood, the Journal of the American Society of Hematology (ASH). T-ALL is a cancer of the white blood cells in which genetic mutations cause normal immature T-cells to develop into leukemic cells, or "blasts." These blasts then ...

New research speaks to educational challenges

2012-04-10
WASHINGTON, April 9, 2012– Education research experts will unveil findings critical to the future of education at the upcoming AERA 2012 Annual Meeting, the largest gathering of education research experts in the world. More than 13,000 participants from over 60 countries plan to attend the meeting from April 13 through 17 in Vancouver, British Columbia, Canada. Researchers will present their latest findings in more than 2,400 sessions, invited lectures, and other events. New peer-reviewed research findings address a wide range of areas in education including the public ...

LAST 30 PRESS RELEASES:

New gene linked to severe cases of Fanconi anemia

METTL3 drives oral cancer by blocking tumor-suppressing gene

Switch to two-point rating scales to reduce racism in performance reviews, research suggests

The Journal of Nuclear Medicine Ahead-of-Print Tip Sheet: May 9, 2025

Stability solution brings unique form of carbon closer to practical application

New research illustrates the relationship between moral outrage on social media and activism

New enzyme capable of cleaving cellulose should revolutionize biofuel production

Krebs von den Lungen-6 as a biomarker for distinguishing between interstitial lung disease and interstitial lung abnormalities based on computed tomography findings

Chimpanzee groups drum with distinct rhythms

Wasp mums use remarkable memory when feeding offspring

Americans’ use of illicit opioids is higher than previously reported

Estimates of illicit opioid use in the U.S.

Effectiveness and safety of RSV vaccine for U.S. adults age 60 or older

Mass General Brigham researchers share tool to improve newborn genetic screening

Can frisky flies save human lives?

Heart rhythm disorder traced to bacterium lurking in our gums

American Society of Plant Biologists names 2025 award recipients

Protecting Iceland’s towns from lava flows – with dirt

Noninvasive intracranial source signal localization and decoding with high spatiotemporal resolution

A smarter way to make sulfones: Using molecular oxygen and a functional catalyst

Self-assembly of a large metal-peptide capsid nanostructure through geometric control

Fatty liver in pregnancy may increase risk of preterm birth

World record for lithium-ion conductors

Researchers map 7,000-year-old genetic mutation that protects against HIV

KIST leads next-generation energy storage technology with development of supercapacitor that overcomes limitations

Urine, not water for efficient production of green hydrogen

Chip-scale polydimethylsiloxane acousto-optic phase modulator boosts higher-resolution plasmonic comb spectroscopy

Blood test for many cancers could potentially thwart progression to late stage in up to half of cases

Women non-smokers still around 50% more likely than men to develop COPD

AI tool uses face photos to estimate biological age and predict cancer outcomes

[Press-News.org] Study reports 2-year outcomes of diabetic macular edema treatment